BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
6 results:

  • 1. Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
    Doorduijn JK; Zijlstra JM; Lugtenburg PJ; Kersten MJ; Böhmer LH; Minnema MC; MacKenzie MA; van Marwijk Kooij R; de Jongh E; Snijders TJF; de Weerdt O; van Gelder M; Hoogendoorn M; Leys RBL; Kibbelaar RE; de Jong D; Chitu DA; Van't Veer MB; Kluin-Nelemans HC
    Br J Haematol; 2020 Aug; 190(3):385-393. PubMed ID: 32150297
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
    Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
    Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancer.
    Cooper MR; Chim H; Chan H; Durand C
    Ann Pharmacother; 2015 Jan; 49(1):107-12. PubMed ID: 25258420
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Ferrario A; Merli F; Luminari S; Stelitano C; Mannina D; Russo M; Mazza P; Marcheselli L; Goldaniga MC; Federico M; Baldini L;
    Ann Hematol; 2011 Mar; 90(3):323-30. PubMed ID: 20848104
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials.
    Tao Z; Toms BB; Goodisman J; Asefa T
    Chem Res Toxicol; 2009 Nov; 22(11):1869-80. PubMed ID: 19817448
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).
    Freund M; Wunsch-Zeddies S; Schäfers M; Wysk J; Seidel I; Hiddemann W; Hanauske AR; Link H; Schmoll HJ; Poliwoda H
    Ann Hematol; 1992 Feb; 64(2):83-7. PubMed ID: 1554799
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.